EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

State-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists

Lisa Saiman iD, Laurie Murray iD, A Whitney Brown iD

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciaf009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Lisa Saiman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Infectious Diseases and Department of Infection Prevention and Control, Columbia University Irving Medical Cent…. Hauptthemen laut MEDLINE: Cystic Fibrosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transformative changes in care for people with cystic fibrosis (CF; pwCF) have occurred, including most recently, the widespread use of CF transmembrane regulator modulator therapy. These novel therapies improve lung function, decrease pulmonary exacerbations, increase life expectancy, and improve quality of life. Changes in the CF population have also occurred. There are now more adults than children living with CF. A growing proportion of pwCF are black and/or Hispanic, many of whom are ineligible for modulator therapy due to their CF transmembrane regulator mutations, which may further exacerbate disparities in healthcare. Management of pulmonary exacerbations—including shared decision making between pwCF and providers, the limitations of antimicrobial susceptibility testing to predict treatment response, and the role of antimicrobial stewardship—is increasingly recognized by the CF community. Collaborations among infectious diseases specialists, antimicrobial stewards, CF care teams, and clinical microbiology laboratories are increasingly needed to optimize these newer care paradigms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisHumansAnti-Bacterial AgentsAntimicrobial StewardshipCystic Fibrosis Transmembrane Conductance Regulator

Stichwörter der Autor:innen

antimicrobial stewardshipcystic fibrosis transmembrane conductance modulatorshared decision makingsocial determinants of health

Substanzen

Anti-Bacterial AgentsCystic Fibrosis Transmembrane Conductance Regulator

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Infectious Diseases and Department of Infection Prevention and Control, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, New York, USA.
  • Department of Pediatrics, Division of Pediatric Pulmonology, Columbia University Irving Medical Center, New York, New York, USA.
  • Cystic Fibrosis Foundation, Bethesda, Maryland, USA.
  • Inova Advanced Lung Disease and Lung Transplant Program, Falls Church, Virginia, USA.

ORCID-Profile: Lisa Saiman, Laurie Murray, A Whitney Brown

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Saiman, L., Murray, L., & Brown, A. W. (2025). State-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf009

Vancouver

Saiman L, Murray L, Brown AW. State-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf009

BibTeX
@article{Saiman2025,
  author = {Saiman, Lisa and Murray, Laurie and Brown, A Whitney},
  title = {State-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciaf009}
}
Kostenlos starten →